Vivo Capital VIII, LLC

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13D · 1 security · may seek to influence control
Sinovac Biotech Ltd. 13D/A SVA · P8696W104	SVA	P8696W104	6.3%	4,541,764	13D/A	7/11/2025 Event 7/11/2025
Vivo Capital VIII, LLC			1.9%	1,361,236
Vivo Capital IX, LLC			6.3%	4,541,764

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.